Spectral CT Scans to Guide Radiotherapy for Cervical Cancer
Studies spectral CT imaging for planning radiotherapy in adults with cervical cancer.
Plain-language title generated from the registry record
Registry title: Spectral CT in Radiotherapy for Cervical Cancer
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with cervical cancer confirmed by pathology who are treated with chemotherapy and radiotherapy together and have spectral CT scans.
- Age
- 18 years or older
- Sex
- Women only
- Disease stage
- Cervical cancer confirmed by pathology. No stage is given.
- Earlier treatment
- Patients are treated with concurrent chemoradiotherapy. All had an 18F-FDG PET/CT before treatment.
Main reasons for not taking part
- CT without spectral scans
- History of allergy to intravenous contrast
- Pregnant or potentially pregnant women
Read by machine on 9 November 2026.
Where in China
- Peking Union Medical College HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Peking Union Medical College Hospital
- Trial code
- NCT06433817
- Record updated
- 30 May 2024
- Original description
The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.Read full original descriptionShow less
The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer
The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.
Inclusion: All patients were confirmed cervical cancer by pathology; patients were treated with concurrent chemoradiotherapy; Spectral CT scans acquisition performed during the arterial phase and venous phase; All the patients underwent a 18F-FDG PET/CT before treatment.
Exclusion: History of allergy to intravenous contrast; CT without spectral scans; Pregnant or potentially pregnant female subjects.